These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
132 related items for PubMed ID: 14695631
1. Risk of bleeding complications with antiplatelet agents: meta-analysis of 338,191 patients enrolled in 50 randomized controlled trials. Serebruany VL, Malinin AI, Eisert RM, Sane DC. Am J Hematol; 2004 Jan; 75(1):40-7. PubMed ID: 14695631 [Abstract] [Full Text] [Related]
2. Bleeding risks of combination vs. single antiplatelet therapy: a meta-analysis of 18 randomized trials comprising 129,314 patients. Serebruany VL, Malinin AI, Ferguson JJ, Vahabi J, Atar D, Hennekens CH. Fundam Clin Pharmacol; 2008 Jun; 22(3):315-21. PubMed ID: 18485150 [Abstract] [Full Text] [Related]
3. Analysis of risk of bleeding complications after different doses of aspirin in 192,036 patients enrolled in 31 randomized controlled trials. Serebruany VL, Steinhubl SR, Berger PB, Malinin AI, Baggish JS, Bhatt DL, Topol EJ. Am J Cardiol; 2005 May 15; 95(10):1218-22. PubMed ID: 15877994 [Abstract] [Full Text] [Related]
4. Antiplatelet profiles of the fixed-dose combination of extended-release dipyridamole and low-dose aspirin compared with clopidogrel with or without aspirin in patients with type 2 diabetes and a history of transient ischemic attack: a randomized, single-blind, 30-day trial. Serebruany VL, Malinin AI, Pokov AN, Hanley DF. Clin Ther; 2008 Feb 15; 30(2):249-59. PubMed ID: 18343263 [Abstract] [Full Text] [Related]
5. Rebound platelet activation after termination of prasugrel and aspirin therapy due to confirmed non-compliance in patient enrolled in the JUMBO Trial. Serebruany VL, Midei MG, Meilman H, Malinin AI, Lowry DR. Int J Clin Pract; 2006 Jul 15; 60(7):863-6. PubMed ID: 16846403 [Abstract] [Full Text] [Related]
8. Combination antithrombotic therapy with antiplatelet agents and anticoagulants for patients with atherosclerotic heart disease. Arjomand H, Cohen M, Ezekowitz MD. J Invasive Cardiol; 2004 May 15; 16(5):271-8. PubMed ID: 15152137 [Abstract] [Full Text] [Related]
9. Aspirin, clopidogrel, and warfarin: is the combination appropriate and effective or inappropriate and too dangerous? Hermosillo AJ, Spinler SA. Ann Pharmacother; 2008 Jun 15; 42(6):790-805. PubMed ID: 18477734 [Abstract] [Full Text] [Related]
10. Secondary stroke prevention with antiplatelet drugs: have we reached the ceiling? Diener HC. Int J Stroke; 2006 Feb 15; 1(1):4-8. PubMed ID: 18706062 [Abstract] [Full Text] [Related]
12. Network meta-analysis: simultaneous meta-analysis of common antiplatelet regimens after transient ischaemic attack or stroke. Thijs V, Lemmens R, Fieuws S. Eur Heart J; 2008 May 15; 29(9):1086-92. PubMed ID: 18349026 [Abstract] [Full Text] [Related]
13. Risk of major bleeding with concomitant dual antiplatelet therapy after percutaneous coronary intervention in patients receiving long-term warfarin therapy. DeEugenio D, Kolman L, DeCaro M, Andrel J, Chervoneva I, Duong P, Lam L, McGowan C, Lee G, DeCaro M, Ruggiero N, Singhal S, Greenspon A. Pharmacotherapy; 2007 May 15; 27(5):691-6. PubMed ID: 17461704 [Abstract] [Full Text] [Related]
14. Antiplatelet and anticoagulant therapy in patients with giant cell arteritis. Lee MS, Smith SD, Galor A, Hoffman GS. Arthritis Rheum; 2006 Oct 15; 54(10):3306-9. PubMed ID: 17009265 [Abstract] [Full Text] [Related]
16. Antiplatelet therapy for the prevention of recurrent stroke and other serious vascular events: a review of the clinical trial data and guidelines. Hankey GJ. Curr Med Res Opin; 2007 Jun 15; 23(6):1453-62. PubMed ID: 17559741 [Abstract] [Full Text] [Related]